Emcure Pharma

{
  "main_header": {
    "sid": 10039308,
    "name": "Emcure Pharma",
    "stock_name": "Emcure Pharma",
    "full_name": "Emcure Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/emcure-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,814.85",
    "chg": 22.15,
    "chgp": "1.24%",
    "dir": 1,
    "prev_price": "1,792.70",
    "mcapval": "35,675.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544210,
    "symbol": "EMCURE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE168P01015",
    "curr_date": "Jun 23, 03:30 PM",
    "curr_time": "01:47 AM",
    "last_traded_at": "Jun 23, 03:30 PM IST",
    "bse_nse_vol": "6.67 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 23, 2026",
    "traded_date_str": "2026 06 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/emcure-pharma-10039308-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Emcure Pharmaceuticals Ltd to 52-Week High of Rs 1901",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-hits-new-52-week-high-at-rs1901-4068714",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/EmcurePharmaceu_priceRelatedfactors_4068714.png",
        "date": "2026-06-23 09:57:52",
        "description": "Surging past its previous peaks, Emcure Pharmaceuticals Ltd reached a fresh 52-week high of Rs 1901 on 23 Jun 2026, marking a significant milestone in its price journey. This advance comes amid a sustained four-day rally that has propelled the stock up by 9.42%, outpacing its sector by 3.71% on the day."
      },
      {
        "title": "Strong Momentum Meets Stretched Valuations as Emcure Pharmaceuticals Ltd Reaches All-Time High",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-stock-hits-all-time-high-at-rs186295-4068584",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/EmcurePharmaceu_priceRelatedfactors_4068584.png",
        "date": "2026-06-23 09:38:06",
        "description": ""
      },
      {
        "title": "Emcure Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/emcure-pharmaceuticals-ltd-is-rated-hold-4067107",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/EmcurePharmaceu_mojoScore_4067107.png",
        "date": "2026-06-22 10:12:49",
        "description": "Emcure Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 June 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Emcure Pharmaceuticals Ltd Technical Momentum Shifts to Bullish Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-technical-momentum-shifts-to-bullish-amid-mixed-indicators-4060498",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/EmcurePharmaceu_technicaldot_4060498.png",
        "date": "2026-06-18 08:05:47",
        "description": "Emcure Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a slight dip in the stock price on 18 Jun 2026, the underlying technical indicators suggest a strengthening momentum that investors should carefully consider amid mixed signals from key oscillators and moving averages."
      },
      {
        "title": "Emcure Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4058283",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/EmcurePharmaceu_technicaldot_4058283.png",
        "date": "2026-06-17 08:06:54",
        "description": "Emcure Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of mid-June 2026. While daily moving averages and monthly Bollinger Bands suggest strength, mixed signals from monthly RSI and weekly On-Balance Volume (OBV) indicators highlight a complex technical landscape for investors to consider."
      },
      {
        "title": "Emcure Pharmaceuticals Ltd Technical Momentum Shifts to Bullish Amid Mixed Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-technical-momentum-shifts-to-bullish-amid-mixed-returns-4055247",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/EmcurePharmaceu_technicaldot_4055247.png",
        "date": "2026-06-16 08:07:58",
        "description": "Emcure Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a recent dip in daily price and a downgrade in its Mojo Grade from Buy to Hold, the stock’s technical indicators suggest improving momentum that investors should carefully analyse amid mixed return performance compared to the broader Sensex."
      },
      {
        "title": "Emcure Pharmaceuticals Ltd’s Mixed Momentum Week: -1.49% Price, +0.57% Sensex",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltds-mixed-momentum-week--149-price-057-sensex-4050689",
        "imagepath": "",
        "date": "2026-06-13 09:05:07",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>8 June:</strong> Stock opens at ₹1,760.50, declines 2.33% amid broad market weakness</p>\n                    <p><strong>9 June:</strong> Technical momentum shifts to mildly bullish; stock rebounds 1.34% to ₹1,742.65</p>\n                    <p><strong>11 June:</strong> Momentum upgrades to bullish despite 0.73% dip; technical indicators mixed</p>\n                    <p><strong>12 June:</strong> Valuation downgrade to Hold; stock closes at ₹1,734.25 with 3.07% gain on final day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹1,760.50</div></div>\n            ..."
      },
      {
        "title": "Emcure Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-signals-4048406",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/EmcurePharmaceu_technicaldot_4048406.png",
        "date": "2026-06-12 08:05:26",
        "description": "Emcure Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend. Despite a recent day decline of 2.73%, the stock’s mixed technical indicators suggest a nuanced outlook for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Emcure Pharmaceuticals Ltd Valuation Shifts Signal Caution Amid Strong Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-valuation-shifts-signal-caution-amid-strong-returns-4048234",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/EmcurePharmaceu_valuationdot_4048234.png",
        "date": "2026-06-12 08:01:08",
        "description": "Emcure Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a very expensive to an expensive rating, reflecting a recalibration in market perception despite delivering robust returns year-to-date. This article analyses the recent changes in key valuation metrics such as price-to-earnings (P/E) and price-to-book value (P/BV) ratios, compares them with peer averages and historical benchmarks, and assesses the implications for investors navigating the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 427,
    "sid": "10039308",
    "stock_news_url": "https://www.marketsmojo.com/news/emcure-pharmaceuticals-10039308"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "19-Jun-2026",
      "details": "Allotment of 20600 Equity Shares pursuant to exercise of ESOPs under Emcure - Employee Stock Option Scheme 2013",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "12-Jun-2026",
      "details": "Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Investor Presentation - June 2026",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "27-May-2026",
      "details": "Annual Secretarial Compliance Report for the Financial Year ended March 31 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Emcure Pharmaceuticals Ltd has declared <strong>30%</strong> dividend, ex-date: 14 Aug 25",
          "dt": "2025-08-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Broad-Based Technical Strength Lifts Emcure Pharmaceuticals Ltd to 52-Week High of Rs 1901

2026-06-23 09:57:52

Surging past its previous peaks, Emcure Pharmaceuticals Ltd reached a fresh 52-week high of Rs 1901 on 23 Jun 2026, marking a significant milestone in its price journey. This advance comes amid a sustained four-day rally that has propelled the stock up by 9.42%, outpacing its sector by 3.71% on the day.

Read full news article

Strong Momentum Meets Stretched Valuations as Emcure Pharmaceuticals Ltd Reaches All-Time High

2026-06-23 09:38:06

Read full news article

Emcure Pharmaceuticals Ltd is Rated Hold

2026-06-22 10:12:49

Emcure Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 June 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Emcure Pharmaceuticals Ltd Technical Momentum Shifts to Bullish Amid Mixed Indicators

2026-06-18 08:05:47

Emcure Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a slight dip in the stock price on 18 Jun 2026, the underlying technical indicators suggest a strengthening momentum that investors should carefully consider amid mixed signals from key oscillators and moving averages.

Read full news article

Emcure Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-06-17 08:06:54

Emcure Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of mid-June 2026. While daily moving averages and monthly Bollinger Bands suggest strength, mixed signals from monthly RSI and weekly On-Balance Volume (OBV) indicators highlight a complex technical landscape for investors to consider.

Read full news article

Emcure Pharmaceuticals Ltd Technical Momentum Shifts to Bullish Amid Mixed Returns

2026-06-16 08:07:58

Emcure Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a recent dip in daily price and a downgrade in its Mojo Grade from Buy to Hold, the stock’s technical indicators suggest improving momentum that investors should carefully analyse amid mixed return performance compared to the broader Sensex.

Read full news article

Emcure Pharmaceuticals Ltd’s Mixed Momentum Week: -1.49% Price, +0.57% Sensex

2026-06-13 09:05:07

Key Events This Week

8 June: Stock opens at ₹1,760.50, declines 2.33% amid broad market weakness

9 June: Technical momentum shifts to mildly bullish; stock rebounds 1.34% to ₹1,742.65

11 June: Momentum upgrades to bullish despite 0.73% dip; technical indicators mixed

12 June: Valuation downgrade to Hold; stock closes at ₹1,734.25 with 3.07% gain on final day

Week Open

₹1,760.50

...

Read full news article

Emcure Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Signals

2026-06-12 08:05:26

Emcure Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend. Despite a recent day decline of 2.73%, the stock’s mixed technical indicators suggest a nuanced outlook for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Emcure Pharmaceuticals Ltd Valuation Shifts Signal Caution Amid Strong Returns

2026-06-12 08:01:08

Emcure Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a very expensive to an expensive rating, reflecting a recalibration in market perception despite delivering robust returns year-to-date. This article analyses the recent changes in key valuation metrics such as price-to-earnings (P/E) and price-to-book value (P/BV) ratios, compares them with peer averages and historical benchmarks, and assesses the implications for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

View All News